Business Description
Bharat Immunologicals & Biologicals Corp Ltd
ISIN : INE994B01014
Compare
Compare
Traded in other countries / regions
524663.India IPO Date
2000-03-10Description
Bharat Immunologicals & Biologicals Corp Ltd is an India-based biotechnology company. It primarily manufactures Oral polio vaccines. In addition, the company also manufactures zinc tablets, diarrhea management kits, and Ready to Use Therapeutic Food (RUTF). It also manufactures nutraceuticals and biological products for the treatment of health deficiencies and disorders. The firm is organized into three segments: Oral Polio Vaccine, Zinc Tablets, and BIB VIT, BIBSANIT. The group principally operates in India and generates the majority of its revenue from sales of Oral polio vaccines.
Financial Strength
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.12 | |||||
| Equity-to-Asset | 0.42 | |||||
| Debt-to-Equity | 0.95 | |||||
| Debt-to-EBITDA | -4.38 | |||||
| Piotroski F-Score | 2/9 | |||||
| Altman Z-Score | 0.02 | |||||
| Beneish M-Score | 2.97 | |||||
| WACC vs ROIC | ||||||
Growth Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -12.6 | |||||
| 3-Year EBITDA Growth Rate | -15.1 | |||||
| 3-Year EPS without NRI Growth Rate | -18.3 | |||||
| 3-Year FCF Growth Rate | -31.6 | |||||
| 3-Year Book Growth Rate | 62.7 |
Momentum Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 71.85 | |||||
| 9-Day RSI | 64.32 | |||||
| 14-Day RSI | 58.98 | |||||
| 6-1 Month Momentum % | 21.3 | |||||
| 12-1 Month Momentum % | 18.66 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.33 | |||||
| Quick Ratio | 0.32 | |||||
| Cash Ratio | 0.09 | |||||
| Days Inventory | 138.33 | |||||
| Days Sales Outstanding | 821.87 | |||||
| Days Payable | 104.47 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | 4.61 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | -27.35 | |||||
| Operating Margin % | -282.31 | |||||
| Net Margin % | -236.13 | |||||
| FCF Margin % | 142.38 | |||||
| ROE % | -20.51 | |||||
| ROA % | -9.22 | |||||
| ROIC % | -6.34 | |||||
| ROC (Joel Greenblatt) % | -13.67 | |||||
| ROCE % | -17.91 | |||||
| Years of Profitability over Past 10-Year | 3 |
GF Value Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Price-to-Owner-Earnings | 12.34 | |||||
| PS Ratio | 16.44 | |||||
| PB Ratio | 1.6 | |||||
| Price-to-Tangible-Book | 1.8 | |||||
| Price-to-Free-Cash-Flow | 11.54 | |||||
| Price-to-Operating-Cash-Flow | 11.54 | |||||
| EV-to-EBIT | -12.29 | |||||
| EV-to-EBITDA | -12.43 | |||||
| EV-to-Revenue | 27.56 | |||||
| EV-to-FCF | 18.09 | |||||
| Price-to-Median-PS-Value | 19.12 | |||||
| Earnings Yield (Greenblatt) % | -8.14 | |||||
| FCF Yield % | 7.68 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Bharat Immunologicals & Biologicals Corp Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 76.503 | ||
| EPS (TTM) (₹) | -4.178 | ||
| Beta | 0.5 | ||
| Volatility % | 41.24 | ||
| 14-Day RSI | 58.98 | ||
| 14-Day ATR (₹) | 1.877409 | ||
| 20-Day SMA (₹) | 30.9055 | ||
| 12-1 Month Momentum % | 18.66 | ||
| 52-Week Range (₹) | 20.5 - 43.89 | ||
| Shares Outstanding (Mil) | 43.18 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Bharat Immunologicals & Biologicals Corp Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Bharat Immunologicals & Biologicals Corp Ltd Stock Events
| Event | Date | Price(₹) | ||
|---|---|---|---|---|
| No Event Data | ||||
Bharat Immunologicals & Biologicals Corp Ltd Frequently Asked Questions
What is Bharat Immunologicals & Biologicals Corp Ltd(BOM:524663)'s stock price today?
The current price of BOM:524663 is ₹32.89. The 52 week high of BOM:524663 is ₹43.89 and 52 week low is ₹20.50.
When is next earnings date of Bharat Immunologicals & Biologicals Corp Ltd(BOM:524663)?
The next earnings date of Bharat Immunologicals & Biologicals Corp Ltd(BOM:524663) is .
Does Bharat Immunologicals & Biologicals Corp Ltd(BOM:524663) pay dividends? If so, how much?
Bharat Immunologicals & Biologicals Corp Ltd(BOM:524663) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers